Results for tag: "Palynziq"

Palynziq is a drug used to treat phenylketonuria (PKU), a rare genetic disorder that affects the metabolism of the amino acid phenylalanine. It is a biologic drug, meaning it is made from living cells, and is the first and only approved therapy for adults with PKU. Palynziq works by reducing the amount of phenylalanine in the body, allowing patients to maintain a healthy level of the amino acid. The Palynziq market is part of the larger Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions, such as diabetes, obesity, and thyroid disorders. These drugs are used to manage symptoms, reduce the risk of complications, and improve quality of life. Companies in the Palynziq market include BioMarin Pharmaceuticals, Inc., which manufactures and markets the drug, as well as other pharmaceutical companies that develop and market drugs for endocrine and metabolic disorders. Show Less Read more